Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,776 across all filing types
Latest filing 2021-07-07 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
金宇生物技术股份有限公司关于最近五年被证券监管部门和交易所采取监管措施或处罚及相关整改措施的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a company regarding regulatory measures and penalties taken by securities regulatory authorities over the past five years, including details of a specific administrative regulatory measure and the company's corrective actions. It does not contain financial statements or detailed financial performance data. The document is a regulatory compliance disclosure related to past regulatory actions and remediation, not a full audit report or annual report. It is a regulatory announcement about compliance and regulatory history, fitting best under Regulatory Filings (RNS). The document length is under 5,000 characters and is an announcement rather than a full report.
2021-07-07 Chinese
金宇生物技术股份有限公司董事会战略委员会议事规则（2021年7月修订）
Governance Information Classification · 95% confidence The document is titled as the 'Rules of Procedure for the Board Strategic Committee' of a company, detailing the composition, responsibilities, decision-making procedures, and meeting rules of a board committee. It is a governance-related document outlining internal rules and governance practices of the board and its committees. There is no financial data, no report of financial results, no announcement of voting results, no audit information, no legal proceedings, no capital changes, no earnings data, and no investor presentation. The document is not an announcement or a brief notice but a detailed governance document. Therefore, it fits best under the category of Governance Information (CGR). The document length is 2022 characters, which is sufficient for a detailed governance report. Confidence is high due to the clear nature of the content and absence of other report types.
2021-07-07 Chinese
金宇生物技术股份有限公司董事会薪酬与考核委员会议事规则（2021年7月修订）
Governance Information Classification · 95% confidence The document is titled as the "Board of Directors Remuneration and Assessment Committee Rules" of a company, detailing the structure, responsibilities, and procedures of the remuneration and assessment committee. It focuses on governance practices related to board and senior management compensation and evaluation. There are no financial statements, earnings data, or regulatory filings. The content is about internal governance rules and committee operations, which fits the definition of Governance Information (CGR). The document length is 2696 characters, which is relatively short but contains substantive governance content, not just an announcement or summary. Therefore, the appropriate classification is CGR with high confidence.
2021-07-07 Chinese
金宇生物技术股份有限公司董事会审计委员会实施细则（2021年7月修订)
Governance Information Classification · 95% confidence The document is titled as the 'Implementation Rules of the Board Audit Committee' of a company, detailing the structure, responsibilities, meeting procedures, and governance of the audit committee. It references relevant laws and governance codes but does not contain financial statements, audit results, or report data. It is a governance-related document outlining internal rules and committee operations rather than an audit report or financial report. Therefore, it fits best under Governance Information (CGR). The document length is 2346 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full financial report.
2021-07-07 Chinese
金宇生物技术股份有限公司独立董事关于公司非公开发行A股股票涉及关联交易事项的事前认可意见
Regulatory Filings
2021-07-07 Chinese
金宇生物技术股份有限公司关于2021年度非公开发行A股股票摊薄即期回报、填补回报措施及相关主体承诺的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding a non-public issuance of A shares, specifically discussing the dilution of immediate returns, measures to compensate for this dilution, and related commitments by the company and its controlling shareholders. It includes detailed financial impact analysis, risk warnings, the necessity and rationality of the issuance, use of proceeds, and commitments to protect shareholder interests. The document references regulatory guidelines and legal compliance but does not contain full financial statements or comprehensive financial performance data. It is primarily an update on capital raising activities and related shareholder protections rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (6321 characters) and content confirm it is a substantive announcement rather than a brief notice or a report publication announcement.
2021-07-07 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.